Back

Optimizing elective high-risk PCI with ECMO support: the value of completely percutaneous use of VA-ECMO

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: All things percutaneous coronary intervention: a potpourri of percutaneous coronary intervention-related topics Protected Percutaneous Coronary Intervention (PCI) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Alexander Griffioen

Radboud University Medical Centre, Nijmegen (Netherlands (The))

9 More presentations in this session

Presentation thumbnail
Examining prognostic scores for short-term major adverse cardiovascular events prediction following primary PCI: a comparative analysis
Doctor U. Safdar (Karachi, PK)
Abstract Slides Video
Presentation thumbnail
Both fibrosis-4 index and fibrosis-5 index can predict the prognosis of patients after percutaneous coronary intervention
Doctor T. Gu (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Very short-term effects of single dose of proprotein convertase subtilisin kexin 9 inhibitor therapy before percutaneous coronary intervention
Doctor T. Kataoka (Fukui, JP)
Abstract Slides Video
Presentation thumbnail
Impact of moderate to severe anemia on clinical outcomes in patients with atrial fibrillation and coronary artery disease requiring percutaneous coronary intervention
Miss K. Abe (Chiba, JP)
Abstract Slides Video
Presentation thumbnail
Assessment of safety, efficacy and learning curve of intravascular lithotripsy in real world practice within a high volume calcium modification centre
Doctor J. Hinton (Bournemouth, GB)
Abstract Slides Video

Access the full session

Session thumbnail
All things percutaneous coronary intervention: a potpourri of percutaneous coronary intervention-related topics

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Full percutaneous angio-guided ECLS implantation reduces major vascular complications as compared to surgical implantation.
thumbnail
Congress Presentation
Safety of venoarterial extracorporeal membrane oxygenation in patients with acute myocardial infarction complicated by cardiogenic shock
thumbnail
Congress Presentation
Do DAN-GER-SHOCK eligible patients benefit from VA-ECMO treatment in infarct-related cardiogenic shock ? Results of an individual patient data meta-analysis.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources